Caplight Directory>Companies>Avesta76 Therapeutics-preview>Avesta76


Avesta76 Therapeutics

Avesta76 Therapeutics

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttp://www.avesta76.com

Last Round

Seed

Nov 6, 2023

Company Overview

Avesta76 Therapeutics is a biotechnology company that operates a drug discovery platform intended to address the need for safe and effective treatments across multiple cancers.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

small molecule drugsoncology therapeuticscancer drugsPI3K/AKT/mTOR inhibitortargeted cancer therapycovalent inhibitorsAKT inhibitordrug discovery platformoral cancer therapypreclinical biotechovarian cancertherapeutic resistancechemo-resistant cancerdrug R&Dpharma licensingprecision oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avesta76 Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Avesta76 Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedNov 6, 2023
View all Funding Rounds

Key People

Founding team and executive leadership

Arjun Awasthi

Co-Founder And Chief Operating Officer

Founding Team

Sanjay Awasthi

Chief Scientific Officer, Chief Scientific Officer, Founder Chairman

Founding Team

Ian Akash Morrison

Co-Founder CEO

Founding Team

Avesta76 Therapeutics Investors

Notable investors and investment history

InvestorRounds
CANCER FUNDSeed
View all Investors

Avesta76 Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Avesta76 Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Avesta76 Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range11
Year Founded2017
Last FundingNov 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.